Glucaric acid

Glucaric acid is a lipid of Fatty Acyls (FA) class. Glucaric acid is associated with abnormalities such as Consumption-archaic term for TB and furuncle. The involved functions are known as Oxidation, Mutation, Process, Cell Growth and Anabolism. Glucaric acid often locates in BL21, Clone and host. The associated genes with Glucaric acid are MIOX gene, ISYNA1 gene, Genome and Candidate Disease Gene. The related experimental models are Knock-out.

Cross Reference

Introduction

To understand associated biological information of Glucaric acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Glucaric acid?

Glucaric acid is suspected in and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Glucaric acid

MeSH term MeSH ID Detail
Telangiectasia, Hereditary Hemorrhagic D013683 1 associated lipids
Hemosiderosis D006486 1 associated lipids
Rickets, Hypophosphatemic D063730 1 associated lipids
Calcium Metabolism Disorders D002128 1 associated lipids
Anemia, Neonatal D000751 1 associated lipids
Per page 10 20 50 100 | Total 85

PubChem Associated disorders and diseases

What pathways are associated with Glucaric acid

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Glucaric acid through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Glucaric acid?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Glucaric acid?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Glucaric acid?

There are no associated biomedical information in the current reference collection.

What genes are associated with Glucaric acid?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Glucaric acid?

Knock-out

Knock-out are used in the study 'Evolution-guided optimization of biosynthetic pathways.' (Raman S et al., 2014).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Glucaric acid

Download all related citations
Per page 10 20 50 100 | Total 1061
Authors Title Published Journal PubMed Link
pmid:
pmid:10050710
pmid:10050711
Mezey E Increased urinary excretion of D-glucaric acid in alcoholism. 1976 Res. Commun. Chem. Pathol. Pharmacol. pmid:1005917
Warrander A and Waring RH An improved method for gas chromatographic determination of urinary xylitol and glucuronic, glucaric gulonic and ascorbic acids, with their values in the rat, rabbit, guinea-pig and marmoset. 1978 Xenobiotica pmid:102085
Nakatsugawa S et al. Inhibitory effect of ND2001 on spontaneous multiple metastasis of NC 65 tumors derived from human renal cancer cells intradermally transplanted into nude mice. 1999 Anticancer Drugs pmid:10211554
Latham AN and Sweeney GD Binding of anticonvulsant drugs to cytochrome P-450: correlation with evidence of induction of hepatic microsomal enzymes. 1976 Can. J. Physiol. Pharmacol. pmid:1021219
pmid:10233353
Düllmann J et al. [Iron storage and metabolism in nacrophages and endothelial cells after intravenous administration of colloidal ferric saccharate in man]. 1976 Verh Anat Ges pmid:1024396
Rycroft D and Daniel JW The excretion of D-glucaric acid in the urine of human volunteers following the administration of disopyramide. 1976 J. Int. Med. Res. pmid:1026531
Weisbach V et al. Oral or intravenous iron as an adjuvant to autologous blood donation in elective surgery: a randomized, controlled study. 1999 Transfusion pmid:10335995
Gasche C et al. Sequential treatment of anemia in ulcerative colitis with intravenous iron and erythropoietin. 1999 Digestion pmid:10343140
Picaud JC et al. [Iron supplementation in preterm infants treated with erythropoietin]. 1999 Arch Pediatr pmid:10394459
Krafft A et al. Erythropoietic quality of maternal milk. 1999 Lancet pmid:10475225
Lim PS et al. Enhanced oxidative stress in haemodialysis patients receiving intravenous iron therapy. 1999 Nephrol. Dial. Transplant. pmid:10534512
Mariani G et al. Detection of acute myocardial infarction by 99mTc-labeled D-glucaric acid imaging in patients with acute chest pain. 1999 J. Nucl. Med. pmid:10565778
Lubberink M et al. Quantification aspects of patient studies with 52Fe in positron emission tomography. 1999 Appl Radiat Isot pmid:10581681
Yoshimi N et al. Inhibition of azoxymethane-induced rat colon carcinogenesis by potassium hydrogen D-glucarate. 2000 Int. J. Oncol. pmid:10601547
Braun L et al. Different induction of gulonolactone oxidase in aromatic hydrocarbon-responsive or -unresponsive mouse strains. 1999 FEBS Lett. pmid:10606751
Jahn M et al. The reaction of hyaluronic acid and its monomers, glucuronic acid and N-acetylglucosamine, with reactive oxygen species. 1999 Carbohydr. Res. pmid:10614067
Bailie GR et al. Parenteral iron use in the management of anemia in end-stage renal disease patients. 2000 Am. J. Kidney Dis. pmid:10620537
Descombes E and Fellay G Improved response to erythropoietin therapy with long-term continuous iron supplementation. 2000 Nephron pmid:10657727
Fujii Y et al. Inhibition of liver metastases and tumor cell invasion in spontaneous liver metastasis model (LMFS) by sodium D-glucaro-delta-lactam (ND2001). 2000 Biomed. Pharmacother. pmid:10759292
Monterrubio R et al. A common regulator for the operons encoding the enzymes involved in D-galactarate, D-glucarate, and D-glycerate utilization in Escherichia coli. 2000 J. Bacteriol. pmid:10762278
Gulick AM et al. Evolution of enzymatic activities in the enolase superfamily: crystallographic and mutagenesis studies of the reaction catalyzed by D-glucarate dehydratase from Escherichia coli. 2000 Biochemistry pmid:10769114
Wiersema AM et al. Early assessment of skeletal muscle damage after ischaemia-reperfusion injury using Tc-99m-glucarate. 2000 Cardiovasc Surg pmid:10799826
Fujita K et al. Establishment of Salmonella strain expressing catalytically active human UDP-glucuronosyltransferase 1A1 (UGT1A1). 2000 Life Sci. pmid:10821120
Wargovich MJ et al. Efficacy of potential chemopreventive agents on rat colon aberrant crypt formation and progression. 2000 Carcinogenesis pmid:10837003
Lai AA and Levy RH Pharmacokinetic description of drug interactions by enzyme induction: carbamazepine-clonazepam in monkeys. 1979 J Pharm Sci pmid:108383
Van Wyck DB et al. Safety and efficacy of iron sucrose in patients sensitive to iron dextran: North American clinical trial. 2000 Am. J. Kidney Dis. pmid:10873877
Gombotz H et al. Preoperative treatment with recombinant human erythropoietin or predeposit of autologous blood in women undergoing primary hip replacement. 2000 Acta Anaesthesiol Scand pmid:10903019
Krafft A et al. Intravenous iron sucrose in two pregnant women with inflammatory bowel disease and severe iron deficiency anemia. 2000 Acta Obstet Gynecol Scand pmid:10949245
van Iperen CE et al. Response of erythropoiesis and iron metabolism to recombinant human erythropoietin in intensive care unit patients. 2000 Crit. Care Med. pmid:10966249
Matsuo E et al. Acid mucopolysaccharide metabolism in leprosy. 3. Hyaluronic acid mycobacterial growth enhancement, and growth suppression by saccharic acid and vitamin C as inhibitors of beta-glucuronidase. 1975 Jan-Mar Int. J. Lepr. Other Mycobact. Dis. pmid:1099016
Parkkinen J et al. Catalytically active iron and bacterial growth in serum of haemodialysis patients after i.v. iron-saccharate administration. 2000 Nephrol. Dial. Transplant. pmid:11071973
Kao HH et al. Clinical characteristic of parenteral iron supplementation in hemodialysis patients receiving erythropoietin therapy. 2000 Chang Gung Med J pmid:11126152
Fishbane S and Kowalski EA The comparative safety of intravenous iron dextran, iron saccharate, and sodium ferric gluconate. 2000 Nov-Dec Semin Dial pmid:11130261
Pollak A et al. Effect of intravenous iron supplementation on erythropoiesis in erythropoietin-treated premature infants. 2001 Pediatrics pmid:11134438
Johnson LL et al. Technetium-99m glucarate uptake in a swine model of limited flow plus increased demand. 2000 Nov-Dec J Nucl Cardiol pmid:11144474
Charytan C et al. Efficacy and safety of iron sucrose for iron deficiency in patients with dialysis-associated anemia: North American clinical trial. 2001 Am. J. Kidney Dis. pmid:11157370
pmid:11217959
Kosch M and Schaefer RM [Iron deficiency. When parenteral substitution?]. 2001 MMW Fortschr Med pmid:11247361
Breymann C et al. Efficacy and safety of intravenously administered iron sucrose with and without adjuvant recombinant human erythropoietin for the treatment of resistant iron-deficiency anemia during pregnancy. 2001 Am. J. Obstet. Gynecol. pmid:11262469
pmid:11273875
Stoves J et al. A randomized study of oral vs intravenous iron supplementation in patients with progressive renal insufficiency treated with erythropoietin. 2001 Nephrol. Dial. Transplant. pmid:11328902
Talafant E et al. Glucaric acid excretion as index of hepatic glucuronidation in neonates after phenobarbital treatment. 1975 Pediatr. Res. pmid:1134846
Levy G et al. Pharmacokinetics of acetaminophen in the human neonate: formation of acetaminophen glucuronide and sulfate in relation to plasma bilirubin concentration and D-glucaric acid excretion. 1975 Pediatrics pmid:1134883
pmid:11390726
Pach J et al. New possibilities in scintigraphy detection of carbon monoxide cardiotoxicity. 2001 Prz. Lek. pmid:11450331
Prakash S et al. Experience with a large dose (500 mg) of intravenous iron dextran and iron saccharate in peritoneal dialysis patients. 2001 May-Jun Perit Dial Int pmid:11475345
pmid:11483144
Gasche C et al. Prediction of response to iron sucrose in inflammatory bowel disease-associated anemia. 2001 Am. J. Gastroenterol. pmid:11513178
pmid:11513584
Murchison LE et al. Effects of anticonvulsants and inactivity on bone disease in epileptics. 1975 Postgrad Med J pmid:1161672
Talafant E et al. Serum gamma-glutamyl transpeptidase activity and urinary D-glucaric acid excretion in newborns in the first week of life. Effects of phenobarbital and nicethamide combination. 1976 Acta Paediatr Scand pmid:11634
Merbouh N et al. Facile nitroxide-mediated oxidations of D-glucose to D-glucaric acid. 2001 Carbohydr. Res. pmid:11675028
Chandler G et al. Intravenous iron sucrose: establishing a safe dose. 2001 Am. J. Kidney Dis. pmid:11684551
Kaltwasser JP et al. Effect of recombinant human erythropoietin and intravenous iron on anemia and disease activity in rheumatoid arthritis. 2001 J. Rheumatol. pmid:11708414
Duffy CI Iron sucrose or ferric gluconate? 2001 Am. J. Kidney Dis. pmid:11728988
Hörl WH Re: Experience with a large dose (500 mg) of intravenous iron dextran and iron saccharate in peritoneal dialysis patients. 2001 Sep-Oct Perit Dial Int pmid:11757843
pmid:11794536
Cassimos C et al. Urinary D-glucaric acid excretion in children with dystonic reactions caused by antiemetic drugs. 1975 J. Pediatr. pmid:1185409
Bayoumeu F et al. [Antipublic antibodies and pregnancy: use of iron sucrose in autologous blood donation with cryopreservation]. 2002 Ann Fr Anesth Reanim pmid:11878118
Rooyakkers TM et al. Ferric saccharate induces oxygen radical stress and endothelial dysfunction in vivo. 2002 Eur. J. Clin. Invest. pmid:11886426
Kooistra MP et al. Nontransferrin-bound iron in the plasma of haemodialysis patients after intravenous iron saccharate infusion. 2002 Eur. J. Clin. Invest. pmid:11886430
pmid:11887828
Hornez JP et al. [Demonstration of different metabolic pathways starting with glucose or fructose in Rhizobium meliloti]. 1976 C.R. Hebd. Seances Acad. Sci., Ser. D, Sci. Nat. pmid:11894
Arteaga de Murphy C et al. 99mTc-glucarate for detection of isoproterenol-induced myocardial infarction in rats. 2002 Int J Pharm pmid:11897407
pmid:11903138
Bayoumeu F et al. Iron therapy in iron deficiency anemia in pregnancy: intravenous route versus oral route. 2002 Am. J. Obstet. Gynecol. pmid:11904617
Marselos M et al. Evidence that D-glucaro-1,4-lactone shortens the pharmacological action of drugs being disposed via the bile as glucuronides. 1975 Biochem. Pharmacol. pmid:1191334
Dittrich E et al. Efficacy of a low-dose intravenous iron sucrose regimen in peritoneal dialysis patients. 2002 Jan-Feb Perit Dial Int pmid:11929146
Sandstad O et al. D-glucaric acid in common duct bile and relation to choledocholithiasis. 2002 Scand. J. Gastroenterol. pmid:11989842
Ibert M et al. Determination of the side-products formed during the nitroxide-mediated bleach oxidation of glucose to glucaric acid. 2002 Carbohydr. Res. pmid:12039549
Hosoya S et al. Identification and characterization of the Bacillus subtilis D-glucarate/galactarate utilization operon ycbCDEFGHJ. 2002 FEMS Microbiol. Lett. pmid:12044674
Harmankaya O and Eran A Low-dose intravenous iron administration in chronic hemodialysis patients treated with recombinant human erythropoietin. 2002 Ren Fail pmid:12071600
Zager RA et al. Parenteral iron formulations: a comparative toxicologic analysis and mechanisms of cell injury. 2002 Am. J. Kidney Dis. pmid:12087566
pmid:12109887
Perewusnyk G et al. Parenteral iron therapy in obstetrics: 8 years experience with iron-sucrose complex. 2002 Br. J. Nutr. pmid:12117422
Hermida J et al. Relationship between changes in drug score, D-glucaric acid excretion, and gamma-glutamyltransferase and beta-glucuronidase serum activities during anticonvulsant treatment. 2002 Clin. Lab. pmid:12146576
Calcium-D-glucarate. 2002 Altern Med Rev pmid:12197785
Silverberg DS et al. The correction of anemia in severe resistant heart failure with erythropoietin and intravenous iron prevents the progression of both the heart and the renal failure and markedly reduces hospitalization. 2002 Clin. Nephrol. pmid:12227725
Lecamwasam DS Hepatic enzyme induction and its relationship to urinary D-glucaric acid excretion in man. 1975 Br J Clin Pharmacol pmid:1234021
Lecamwasam DS et al. Effect of phenobarbitone on hepatic drug-metabolizing enzymes and urinary D-glucaric acid excretion in man. 1975 Br J Clin Pharmacol pmid:1234506
Michaud L et al. Tolerance and efficacy of intravenous iron saccharate for iron deficiency anemia in children and adolescents receiving long-term parenteral nutrition. 2002 Clin Nutr pmid:12381338
Kaizu T [Non-dialyzable beta-glucuronidase inhibitor in guinea-pig urine. I. Purification (author's transl)]. 1975 Yakugaku Zasshi pmid:1238533
Tutor-Crespo MJ et al. [A study of some indirect biochemical markers in the evaluation of enzymatic induction caused by antiepileptic drugs]. 2002 Oct 16-31 Rev Neurol pmid:12402220
pmid:12407646
Oldham FB Continuity of research outcomes: the correlation of bench toxicity mechanisms to clinical outcomes--are they dependable? 2002 Am. J. Kidney Dis. pmid:12407662
Boase S and Miners JO In vitro-in vivo correlations for drugs eliminated by glucuronidation: investigations with the model substrate zidovudine. 2002 Br J Clin Pharmacol pmid:12445028
pmid:12455582
Yee J and Besarab A Iron sucrose: the oldest iron therapy becomes new. 2002 Am. J. Kidney Dis. pmid:12460028
Oka H et al. Increased urinary excretion of L-xylulose in patients with liver cirrhosis. 1976 Clin. Chim. Acta pmid:1248150
Bauer S et al. Differential effects of Saint John's Wort (hypericum perforatum) on the urinary excretion of D-glucaric acid and 6beta-hydroxycortisol in healthy volunteers. 2002 Eur. J. Clin. Pharmacol. pmid:12483450
Wali A et al. Comparative study--efficacy, safety and compliance of intravenous iron sucrose and intramuscular iron sorbitol in iron deficiency anemia of pregnancy. 2002 J Pak Med Assoc pmid:12532571
Chuang CL et al. Early prediction of response to intravenous iron supplementation by reticulocyte haemoglobin content and high-fluorescence reticulocyte count in haemodialysis patients. 2003 Nephrol. Dial. Transplant. pmid:12543894
Breymann C Iron deficiency and anaemia in pregnancy: modern aspects of diagnosis and therapy. 2002 Nov-Dec Blood Cells Mol. Dis. pmid:12547241
Escartin Marin P et al. [Enzyme induction in alcoholic and cryptogenetic cirrhoses]. 1976 Rev Esp Enferm Apar Dig pmid:1257561
Folkert VW et al. Chronic use of sodium ferric gluconate complex in hemodialysis patients: safety of higher-dose (> or =250 mg) administration. 2003 Am. J. Kidney Dis. pmid:12612989
Beshara S et al. Pharmacokinetics and red cell utilization of 52Fe/59Fe-labelled iron polymaltose in anaemic patients using positron emission tomography. 2003 Br. J. Haematol. pmid:12614222